Evidence map›Paper›PMID 25061114›Full record

ArticleInvestigative ophthalmology & visual science2014

Elevated transforming growth factor β1 in plasma of primary open-angle glaucoma patients.

John Kuchtey, Jessica Kunkel, L Goodwin Burgess, Megan B Parks, Milam A Brantley, Rachel W Kuchtey

Open access · hybridAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Oral administration of a dual ETMolecular vision · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. T-Lymphocyte Subset Distribution and Activity in Patients With Glaucoma.Investigative ophthalmology & visual science · 2019
    Article
  11. Article
  12. Comparison of T Helper Cell Patterns in Primary Open-Angle Glaucoma and Normal-Pressure Glaucoma.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  13. Article
  14. Article
  15. Antifibrotic effects of pirfenidone on Tenon's fibroblasts in glaucomatous eyes: comparison with mitomycin C and 5-fluorouracil.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2015
    Article
  16. The Thrombospondin1-TGF-β Pathway and Glaucoma.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

John KuchteyVanderbilt Eye Institute, Vanderbilt University, Nashville, Tennessee, United States.
Jessica KunkelVanderbilt Eye Institute, Vanderbilt University, Nashville, Tennessee, United States.
L Goodwin BurgessVanderbilt Eye Institute, Vanderbilt University, Nashville, Tennessee, United States.
Megan B ParksVanderbilt Eye Institute, Vanderbilt University, Nashville, Tennessee, United States.
Milam A BrantleyVanderbilt Eye Institute, Vanderbilt University, Nashville, Tennessee, United States.
Rachel W KuchteyVanderbilt Eye Institute, Vanderbilt University, Nashville, Tennessee, United States.
Vanderbilt Health · USVanderbilt University · US

Funding

Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
Targeting Tissue Biomechanics for Treatment of GlaucomaR01EY020894 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KUCHTEY, RACHEL W · 2010 to 2025
$6.4M
Metabolomic and Genetic Interactions in Age-Related Macular DegenerationR01EY022618 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BRANTLEY, MILAM A · 2013 to 2017
$2.3M
NEI NIH HHS EY020894NEI NIH HHS EY022618NEI NIH HHS P30 EY008126NEI NIH HHS P30EY008126NEI NIH HHS R01 EY020894NEI NIH HHS R01 EY022618
6 · The paper itself

Abstract

purposeTo test the hypothesis that primary open-angle glaucoma (POAG) patients have a systemic elevation of transforming growth factor β1 (TGFβ1).

methodsPlasma was prepared from blood samples drawn from patients of the Vanderbilt Eye Institute during clinic visits. Concentrations of total TGFβ1 and thrombospondin-1 (TSP1) in plasma were determined by ELISA. Statistical significance of differences between POAG and control samples was evaluated by Mann-Whitney test. Regression analysis was used to evaluate correlations between plasma TGFβ1 and patient age and between plasma TGFβ1 and TSP1.

resultsPlasma samples were obtained from 148 POAG patients and 150 controls. Concentration of total TGFβ1 in the plasma of POAG patients (median = 3.25 ng/mL) was significantly higher (P < 0.0001) than in controls (median = 2.46 ng/mL). Plasma TGFβ1 was not correlated with age of patient (P = 0.17). Thrombospondin-1 concentration was also significantly higher (P < 0.0001) in POAG patients (median = 0.774 μg/mL) as compared to controls (median = 0.567 μg/mL). Plasma total TGFβ1 and TSP1 concentrations were linearly correlated (P < 0.0001).

conclusionsPlasma samples from POAG patients display elevated total TGFβ1 compared to controls, consistent with elevated systemic TGFβ1 in POAG patients.

Indexed as

AgedCase-Control StudiesEnzyme-Linked Immunosorbent AssayFemaleGlaucoma, Open-AngleHumansMaleMiddle AgedRegression AnalysisThrombospondin 1Transforming Growth Factor beta1Thrombospondin 1Transforming Growth Factor beta1aqueous humorglaucomaplasmaplatelettransforming growth factor beta

Identifiers

PMID25061114
PMCPMC4142830
OpenAlexW2046876329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.